Rehabtronics Inc.: federal grants and contributions: 16 agreements; $1.4M value; 2 departments; 6 programs.
Assay record ASY-CA-0IOKM2W06Y · Cite as: Assay Systems, “Rehabtronics Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/rehabtronics-inc/
This is an IRAP International project (EUREKA Clusters ITEA,TREAT, ID# 22022) for a consortium led by My Viva Inc. (Canadian). As part of the international consortium project, Rehabtronics will further develop the Prelivia product line. Prelivia is a first-in-class intervention for pressure injuries (PIs), which are a deadly medical complication. This project supports Prelivia's product strategy through the development and implementation of Internet of Medical Things connectivity, AI-driven patient monitoring and digital health ecosystem interoperability. The outcomes of this project will l
The proposed project aims to further develop means of controlled neurostimulation of the body parts that are at risk of developing pressure injuries /bed sores during long hospitalization. The focus is on easy to use, flexible and cost effective pad technology that incorporate smart sensors.
The proposed project aims to advance technical solution for treating Pressure Injury and bring the Prelivia IES-1 Pressure Injury Prevention System from TRL7 to TRL 8 stage. Project involves verification and validation testing, 3rd-party certifications and application for market clearance by the FDA.
In this project Rehabtronics aims to develop a direct-to-clinic(customer) Go-to-market (export) strategy, and validate this strategy by establishing direct-to-clinic networks in 5 international markets.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The project involves assessment and validation of the ReGrasp™ technology in real-world market settings in 3 key EU markets with ultimate goal to increase the market share for ReGrasp™ medical device in Europe.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The purpose of this CanExport - Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Participation in the ITEA International Customers and End-Users Workshop on Smart Health held in Eindhoven, Netherlands, from June 15-16, 2022 to establish relationships with key customers, end-users, and other international firms, which will help set the stage for potential Canadian projects in the upcoming EUREKA ITEA Cluster call for proposals.
Participation in the ITEA PO Days held in Helsinki, Finland, Sept 12-16, 2022. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to establish relationships with key customers, end-users, and other international firms, which will help set the stage for potential Canadian projects in the upcoming EUREKA ITEA Cluster call for proposals.
Participation in the NRC IRAP’s EFECS mission held in Amsterdam, Netherlands, on November 23-25, 2022, led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop international partnerships and potential project ideas for the 2022 Xecs Call for Proposals.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.